Udayavni Special

Serum Institute defends vaccine pricing, says initial rates based on advance funding


PTI, Apr 24, 2021, 4:25 PM IST

New Delhi: Serum Institute of India, which makes the most used COVID-19 vaccine in the country, on Saturday defended pricing Covishield vaccine at 1.5 times the initial rate, saying the earlier price was based on advance funding and now it has to invest in scaling up and expanding capacity to produce more shots.

Serum Institute of India (SII), which manufactures AstraZeneca’s vaccine Covishield at its Pune facility, earlier this week announced a price of Rs 600 per dose and at Rs 400 for State governments and any new contract by the Central government.

This compared to Rs 150 per dose it charges the Central government for the existing supplies.

”There was an inaccurate comparison done between the global prices of the vaccine with India,” SII said. ”Covisheld is the most affordable Covid-19 vaccine available in the market today.”

The initial price, it said, was ”kept low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing.”

”The initial supply price of Covishield for all government immunization programme, including India, has been the lowest,” it said. ”The current situation is extremely dire, the virus is constantly mutating while the public remains at risk. Identifying the uncertainty, we have to ensure sustainability as we must be able to invest in scaling up and expanding our capacity to fight the pandemic and save lives.”

SII went on to add that only a limited portion of SII’s volume will be sold to private hospitals at Rs 600 per dose.

”The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat COVID-19 and other life-threatening diseases,” it added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

PM Modi govt showing bias against Karnataka in allocating Covid resources, alleges HDK

Siddaramaiah accuses state government of giving wrong information on debt

States fighting with one another for vaccines portrays bad image of country: Kejriwal

Govt panel suggests increasing gap between two doses of Covishield

K’taka HC asks govt to submit action plan to counter the potential third wave of Covid-19

Centenarian Doreswamy back home after winning COVID battle in mere five days

COVID-19: India logs 3.62 lakh new cases, 4,120 fresh fatalities



Related Articles More

US-approved vaccines effective against B.1.617 variant of Covid-19: Official

Karnataka: Vaccination drive for 18-44 age group ‘temporarily suspended’

COVID-19: BBMP admits vaccine shortage in B’luru

Govt approves procurement of 1.5 lakh units of DRDO’s ‘Oxycare’ system

A Ramzan like no other: COVID shadow on Muslim fasting month

MUST WATCH

Cyclone Warning on the Coast

Oxygen-Concentrator provided at doorstep with the help of cabs

Chennai Police Danced To Raise Covid-19 Awarenes

Udayavani 12 -May -2021 News Bulletin

Udupi Shiroor mutt successor | Aniruddha Saralatthaya,

Latest Additions

PM Modi govt showing bias against Karnataka in allocating Covid resources, alleges HDK

Siddaramaiah accuses state government of giving wrong information on debt

50 employees of Bharat Biotech test COVID-19 positive; Joint MD’s tweet draws bouquets and brickbats

States fighting with one another for vaccines portrays bad image of country: Kejriwal

Govt panel suggests increasing gap between two doses of Covishield

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.